CHMP Recommends argenx Treatment for Chronic Inflammatory Demyelinating Polyneuropathy
The company said that Vyvgart (efgartigimod alfa) is the first novel mechanism of action for CIDP treatment in more than 30 years.
https://www.pharmtech.com/view..../chmp-recommends-arg
Discover the world at Altruu, The Discovery Engine